Evaluation of drug-related problems identified and pharmaceutical
interventions in the wards of a maternity hospital
Abstract
Purpose: The study aims to identify the profile of Medication-Related
Problems (DRP) and pharmaceutical interventions in a Maternity Hospital.
Methods: The research was conducted in a Maternity Hospital in Santa
Cruz (RN) and adopted a retrospective observational approach. Secondary
data were collected from patients hospitalized in wards with clinical
pharmacy services between January and December 2021. The analysis
included the identification of DRPs, recording of non-compliance rates,
and evaluation pharmaceutical interventions conducted. Results: 8.355
prescriptions were confirmed and a total of 38.048 medications
prescribed in 2021. Prescription error rates by sector were 15,8% in
WAU, 10,5% In pediatrics and 3,7% in the NICU. 359 pharmaceutical
interventions were carried out, 14,4% were in the WAU, 24,2% in
pediatrics and 61.4% in the NICU. The most frequent WAU DRPs included
infusion time (43,9%), speed (23,8%), and dilution (17,3%). In
pediatrics, they were infusion time (45,3%), dose (20,1%) and interval
(15,2%). Finally, those from the NICU included infusion time (39,4%),
dose (25,3%), and dosage (19,9%). Accessibility rates for
interventions were 77% in UASM, 83% in pediatrics, and 77% in the
NICU. Conclusions: Our study underscores the critical role of clinical
pharmacists and multidisciplinary collaboration in enhancing patient
safety. The NICU’s lower error rates highlight the benefits of an
integrated team, while the WAU reveals the need for better professional
interaction to reduce errors and improve intervention acceptance.
Implementing dedicated clinical pharmacists and effective
multidisciplinary practices across all sectors is important for
improving patient care quality and safety.